- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Androgen AntibodyRabbit Monoclonal Antibody
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AJ1043a | 100ul 400 ul | 2-3 days | $ 315.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Androgen Antibody - Product info | |
| Application | WB
|
| Primary Accession | P10275 |
| Reactivity | Human, Mouse, Rat |
| Clone Names | EP670Y |
| Calculated MW | 98989 Da |
| Gene ID 367 | |
| Other Names AR, DHTR, NR3C4, Androgen receptor, Dihydrotestosterone receptor;Nuclear receptor subfamily 3 group C member 4 | |
| Target/Specificity A synthetic peptide corresponding to residues on the C-terminus of human Androgen Receptor was used as an immunogen. | |
| Dilution WB~~1:1000~5000 | |
| Format 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions Androgen Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
Androgen Antibody - Protein Information | |
| Name AR | |
| Synonyms DHTR, NR3C4 | |
| Function Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3 | |
| Cellular Location Nucleus. Cytoplasm. Note=Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence of GNB2L1 | |
| Tissue Location Isoform 2 is mainly expressed in heart and skeletal muscle | |
Androgen Antibody - Related products
AP2509a: Androgen Receptor (ANDR) Antibody
AP10111c: AR Antibody (Center)
AP13058c: AR Antibody (Center)
AP13255c: AR Antibody (Center)
BP10111c: AR Antibody (Center) Blocking peptide
Androgen Antibody - Application data
-
A. Western blot analysis on LnCaP cell lysate using anti-AR RabMAb (Cat. #AJ1043a), dilution 1:10,000
Androgen Antibody - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Androgen receptor (AR) is a member of the steroid receptor superfamily that may require coactivators for proper or maximal transactivation. (1). The androgen receptor (AR) is essential for the growth of prostate cancer cells. It has been reported that tyrosine phosphorylation of AR is induced by growth factors and elevated in hormone-refractory prostate tumors. Data suggest that growth factors and their downstream tyrosine kinases, which are elevated during hormone-ablation therapy, can induce tyrosine phosphorylation of AR and such modification may be important for prostate tumor growth under androgen-depleted conditions (2). Cellular signaling occurs following androgen binding to the AR and translocation to the nucleus. This activated complex associates with androgen-responsive elements contained in the DNA sequence of target genes, affecting the transcriptional activity of these genes. Mutations may result in changes in the function or expression of AR protein, or of growth factors and their receptors under the influence of AR coactivators, and AR amplification could lead to activation of the receptor by reduced levels of androgens (3).
REFERENCES
1. Callewaert L, et al. Biochem Biophys Res Commun 306(1) 46-52, 2003.
2. Qiu Y, et al. Cancer Cell Vol 10:309-319, 2006.
3. Hamdy F, et al. Nature Clinical Practice Urology 2:368-399 2005.
